Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Go back to Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
(NASDAQ: CODX) Delayed: 1.15 +0.05 (4.55%)
Previous Close $1.10    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.17    P/E N/A 
Day Low $1.09    EPS $ 
Volume 435,153